AbbVie Inc - Total Debt To Ebitda

AbbVie Inc's Fiscal Year is From January To December.

The item "Total-Debt-To-Ebitda" stands at 5.40 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of AbbVie Inc's third quarter, the item "Total Debt To Ebitda" stands at 5.40. This represents an increase of 8.57 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 38.55 percent compared to the value the year prior.
The 1 year change in percent is 38.55.
The 3 year change in percent is 96.51.

The Serie's long term average value is 3.69. It's latest available value, on 09/30/2025, is 46.42 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +105.89%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.